Methyl prednisolone sodium succinate for injection


Product Details
img
Name Of Product(Genric Name) :

Methyl prednisolone sodium succinate for injection

Dosage :

125MG/500MG/1GM

Product Description :

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION

Sterile Powder for Solution for Intravenous or Intramuscular Administration

  1. COMPOSITION

Each vial contains:

Methylprednisolone Sodium Succinate equivalent to Methylprednisolone ..............40mg

Excipients: As applicable.

  1. PHARMACEUTICAL FORM

Sterile, white to off-white powder for solution for intravenous or intramuscular administration.

  1. THERAPEUTIC CLASS

Corticosteroid / Glucocorticoid

  1. INDICATIONS

Methylprednisolone Sodium Succinate for Injection is indicated when corticosteroid therapy is required and oral therapy is not feasible or when rapid systemic treatment is clinically appropriate.

It may be used in the treatment of:

• Severe allergic and hypersensitivity reactions
• Acute exacerbations of inflammatory disorders
• Rheumatic and musculoskeletal disorders
• Severe dermatological disorders
• Certain respiratory disorders
• Autoimmune and inflammatory conditions
• Other corticosteroid-responsive conditions as clinically appropriate

Treatment should be used according to the approved prescribing information.

  1. CONTRAINDICATIONS

Methylprednisolone Sodium Succinate is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation.

It is also contraindicated for use by the intrathecal route.

  1. DRUG INTERACTIONS

Particular consideration may be required with concomitant use of:

• Medicines that affect corticosteroid metabolism
• Antidiabetic medicines
• Anticoagulants
• Diuretics
• Non-steroidal anti-inflammatory drugs (NSAIDs)
• Certain vaccines

The treating physician should review all concomitant medications before administration.

  1. ADMINISTRATION

Methylprednisolone Sodium Succinate for Injection may be administered by intravenous or intramuscular route according to the approved product information.

The contents of the vial should be reconstituted with a suitable compatible diluent under appropriate aseptic conditions.

The reconstituted solution should be administered by a qualified healthcare professional according to the approved product information and institutional protocol.

For Intravenous or Intramuscular Use Only.

  1. STORAGE

Store according to the storage conditions stated on the approved product label.

Protect from excessive heat, moisture and light.

After reconstitution, use within the period specified in the approved product information.

Do not use if the reconstituted solution shows visible particles, precipitation or unexpected discoloration.